wixela-product-image Wixela Inhub (fluticasone propionate and salmeterol inhalation powder), the first substitutable generic of Advair Diskus (GlaxoSmithKline), has been made available by Mylan Mylan ...
HERTFORDSHIRE, England, and PITTSBURGH, May 18, 2019 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced four scientific abstracts from the Wixelaâ„¢ Inhubâ„¢ ...
March 10 (Reuters) - Mylan NV: * MYLAN PHARMACEUTICALS ULC LAUNCHES WIXELA® INHUB® (FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER, USP), THE FIRST AVAILABLE BIOEQUIVALENT ALTERNATIVE TO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback